R.M. Davis Inc’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Sell |
12,209
-5,458
| -31% | -$453K | 0.02% | 157 |
|
|
2025
Q1 | $1.43M | Sell |
17,667
-5,972
| -25% | -$484K | 0.03% | 132 |
|
|
2024
Q4 | $2.13M | Sell |
23,639
-2,859
| -11% | -$257K | 0.04% | 123 |
|
|
2024
Q3 | $2.62M | Sell |
26,498
-2,083
| -7% | -$206K | 0.05% | 114 |
|
|
2024
Q2 | $2.65M | Sell |
28,581
-6,879
| -19% | -$638K | 0.05% | 112 |
|
|
2024
Q1 | $3.36M | Sell |
35,460
-3,292
| -8% | -$312K | 0.07% | 101 |
|
|
2023
Q4 | $3.46M | Sell |
38,752
-8,975
| -19% | -$801K | 0.08% | 103 |
|
|
2023
Q3 | $3.49M | Sell |
47,727
-6,421
| -12% | -$469K | 0.09% | 108 |
|
|
2023
Q2 | $4.51M | Sell |
54,148
-1,437
| -3% | -$120K | 0.11% | 104 |
|
|
2023
Q1 | $4.24M | Sell |
55,585
-7,363
| -12% | -$561K | 0.11% | 103 |
|
|
2022
Q4 | $5.23M | Sell |
62,948
-4,209
| -6% | -$349K | 0.14% | 99 |
|
|
2022
Q3 | $5.33M | Sell |
67,157
-3,901
| -5% | -$309K | 0.15% | 101 |
|
|
2022
Q2 | $5.28M | Sell |
71,058
-13,254
| -16% | -$984K | 0.15% | 101 |
|
|
2022
Q1 | $7.58M | Sell |
84,312
-18,038
| -18% | -$1.62M | 0.18% | 99 |
|
|
2021
Q4 | $11.5M | Sell |
102,350
-15,839
| -13% | -$1.77M | 0.26% | 95 |
|
|
2021
Q3 | $14.9M | Sell |
118,189
-2,944
| -2% | -$370K | 0.37% | 83 |
|
|
2021
Q2 | $16.4M | Buy |
121,133
+12,761
| +12% | +$1.73M | 0.41% | 80 |
|
|
2021
Q1 | $14.7M | Buy |
108,372
+9,676
| +10% | +$1.31M | 0.4% | 78 |
|
|
2020
Q4 | $13.9M | Buy |
98,696
+34,966
| +55% | +$4.92M | 0.4% | 72 |
|
|
2020
Q3 | $7.1M | Buy |
63,730
+44,178
| +226% | +$4.92M | 0.23% | 94 |
|
|
2020
Q2 | $2.19M | Buy |
+19,552
| New | +$2.19M | 0.08% | 109 |
|